Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T11:27:42.047Z Has data issue: false hasContentIssue false

5A - DHEA Is an Effective Treatment for Poor Responders

For

from Section II - IVF Add-ons

Published online by Cambridge University Press:  25 November 2021

Roy Homburg
Affiliation:
Homerton University Hospital, London
Adam H. Balen
Affiliation:
Leeds Centre for Reproductive Medicine
Robert F. Casper
Affiliation:
Mount Sinai Hospital, Toronto
Get access

Summary

Dehydroepiandrosterone (DHEA) is produced primarily from the adrenal gland (85%) under the influence of adrenocorticotropic hormone (ACTH) and to a lesser extent by the ovaries. DHEA is an intermediate in the sex steroid pathway and is converted to testosterone and estradiol within the ovaries. The anti-ageing properties of DHEA were first described in 1996, together with the decline in DHEA with advancing age. In reproductive medicine, DHEA has been hypothesised to play a role in improving folliculogenesis through multiple mechanisms. The first report of a possible benefit from DHEA in an IVF setting was in a case report published in 2005. A 42-year-old woman with an initial diagnosis of reduced ovarian reserve and who had one oocyte retrieved in her first IVF cycle self-medicated concomitantly with over-the-counter DHEA supplements and acupuncture. Her oocyte yield was noted to be steadily increasing with each ovarian stimulation, with 17 oocytes being retrieved after her ninth stimulation attempt.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Nagels, HE, Rishworth, JR, Siristatidis, CS, Kroon, B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015 Nov 26.CrossRefGoogle Scholar
Zhang, Y, Zhang, C, Shu, J, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020 Feb 28;26(2):247–63.CrossRefGoogle ScholarPubMed
Gleicher, N, Weghofer, A, Barad, DH. Antimullerian hormone (AMH) defines, independent of age, low versus good live birth chances in women with severely reduced ovarian reserve. Fertil Steril. 2010;94:2824–7.CrossRefGoogle Scholar
Homburg, R, Opoku, A. Battle-worn: setting up a multi-centre randomised controlled trial in the UK. BioNews 2018;967.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×